About this trial
Additional left atrial appendage isolation during balloon ablation for persistent or long-standing persistent atrial fibrillation can reduce atrial fibrillation reoccurrence within 3-12 months compared to balloon-based pulmonary vein isolation only.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Persistent or long-standing persistent AF (i.e. continuous AF that was/is sustained >7 days or >12 months, respectively)
Age ≥18 and ≤80 years
Indication for AF ablation as per current guidelines
Disqualifiers
Missing informed consent
LAA diameter >25mm 10mm distant from circumflex artery assessed by TEE
Paroxysmal atrial fibrillation
Long-standing persistent atrial fibrillation with a continuous AF duration of >4 years
Trial design
Parallel
Treatments tested in this trial
Control intervention
Procedure/Surgerypatients treated with balloon-based ablation of AF by PVI
Experimental intervention
Procedure/Surgerypatients treated with balloon-based ablation of AF by PVI
Treatment groups
Trial outcomes
Primary outcomes
Time until any documented episode of ATa
Time until any documented episode of atrial tachyarrhythmia (ATa: atrial fibrillation or atrial tachycardia) lasting longer than 30 seconds within 3-12 months after index ablation without antiarrhythmic therapy
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Luebeck
Lead sponsor
IHF GmbH - Institut für Herzinfarktforschung
Collaborator